Hemogenyx Pharmaceuticals PLC Announces Investor Webinar Recording
LONDON, ENGLAND / ACCESSWIRE / July 8, 2022 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that following the live investor webinar presented by Dr Vladislav Sandler, Chief Executive Officer and Co-Founder of Hemogenyx …
Weiterlesen »